Biotech's Recently Under the Microscope, Analyst Coverage

Advaxis, Inc. (NASDAQ: ADXS), a clinical stage biotechnology company, focused on Lm-LLO cancer immunotherapies has announced that Anthony Lombardo, interim chief executive officer, will present a company overview at the Cantor Fitzgerald Global Healthcare Conference being held Sept. 25-27, 2017 in New York. The company’s shares have retreated almost 30% this month. Anavex Life Sciences Corp (NASDAQ: AVXL) was issued U.S. Patent Number 9,750,746 entitled “ANAVEX 2-73 and certain anticholinesterase inhibitors composition and method for neuroprotection. The issued patent offers protection through 2033. After AVXL shares fell over 40% this summer, they have gained some traction and recouped about half of that share loss. Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), announced that the company will exhibit at the upcoming 2017 BioProcess International Conference & Exhibition, being held September 25-28, 2017 in Boston, MA. Avid will showcase the company’s comprehensive range of process development, analytical development, testing and characterization services and high-quality cGMP clinical and commercial biologics manufacturing of monoclonal antibodies and recombinant proteins. The company’s shares retreated over 40% since July. 22^nd Century Group, Inc. (NYSE: XXII) is a plant biotechnology company focused on the level of nicotine in tobacco plants and cannabinoids in cannabis plants. Mitch Zeller, Director, US Food and Drug Administration’s Center for Tobacco Products. Together with FDA Commissioner, Dr. Scott Gottlieb, in August 2017, released an article entitled, “A Nicotine-Focused Framework of Public Health.” The article spells out the FDA’s regulatory authority for mandating non-addictive levels of nicotine in combustible cigarettes. The company’s shares have appreciated over 100% since June, as the U.S. Government continues its crusade against nicotine.

Read our recent analyst coverage of these Biotech stocks under the microscope here READ MORE Copy and paste to browser may be required- http://tradersnewssource.com/biotechs/

DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the subject company in this report to be materially different from the statements made herein.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. The subject Company has not compensated Traders News Source for the creation or dissemination of this report. Traders News Source is the party responsible for issuing the press release and for hosting the full analyst report on Traders News Source website.
NOT FINANCIAL ADVICE
Traders News Source makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Traders News Source is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Traders News Source whatsoever for any direct, indirect or consequential loss arising from the use of this document. Traders News Source expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Traders News Source does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
Source: Traders News Source
Contact: editor@tradersnewssource.com